Last reviewed · How we verify
Alopecia Areata
Approved treatments
- Litfulo · Pfizer
Ritlecitinib irreversibly inhibits JAK3 and TEC kinase family by blocking ATP binding site. - Olumiant · Eli Lilly
- Litfulo · Pfizer
Litfulo works by blocking the activity of a specific enzyme called tyrosine-protein kinase ITK/TSK. - Olumiant · NHS Greater Glasgow and Clyde
- Rodinolone
- Aristospan · Ethypharm
- Litfulo · Pfizer
Litfulo works by blocking the ITK/TSK enzyme, which helps to stop the immune system from attacking hair follicles.
Clinical guidelines
- FDA label — 1L
LITFULO is a kinase inhibitor indicated for the treatment of severe alopecia areata in adults and adolescents 12 years and older. - FDA label — any
Baricitinib is indicated for the treatment of adult and pediatric patients 2 years of age and older with moderate to severe alopecia areata. - FDA label — 2L
Baricitinib is indicated for the treatment of adult and pediatric patients 12 years of age and older with moderate to severe atopic dermatitis who are candidates for systemic therapy. - FDA label — 2L
Baricitinib is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more tumor necrosis factor (TNF) antagonist therapies.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Alopecia Areata patent landscape — cliff calendar, originator estates, attackable patents
- Alopecia Areata treatment landscape brief
- Alopecia Areata treatment updates RSS
Frequently asked questions about Alopecia Areata
What drugs treat Alopecia Areata?
Tracked treatments include Litfulo, Olumiant, Rodinolone, Aristospan.
What is the treatment for Alopecia Areata?
Standard treatment for Alopecia Areata includes Litfulo, Olumiant, Rodinolone, Aristospan. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Alopecia Areata?
FDA label publishes guidelines for Alopecia Areata. 4 guideline references tracked.
Related
- Therapeutic area: All conditions in Dermatology
- Treatment landscape: Alopecia Areata patent cliff · Alopecia Areata CI report
- Treatment: Litfulo · Pfizer
- Treatment: Olumiant · Eli Lilly
- Treatment: Litfulo · Pfizer
- Treatment: Olumiant · NHS Greater Glasgow and Clyde
- Treatment: Rodinolone
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing